Non-neoplastic and Non-infectious DiseasesNCT07301398
Development & Preliminary Validation of a Community Health Education Program
An observational study of Non-neoplastic and Non-infectious Diseases, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine.
Trial summary
This study analyzes the needs of patients regarding the content and form of home-based health education through interviews, and constructs a health education program tailored to these needs. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Non-neoplastic and Non-infectious Diseases
- What is being tested?
- The use and guidance of the mini-program
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 92 participants
- Where
- No sites listed yet
- Study dates
- 30 Dec 2025to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Complicated with other life-threatening diseases; Consciousness disturbance or mental illness; Currently participating in other clinical trials that may affect this study.
Who may be able to join
- Patients diagnosed with interstitial lung disease; Aged 18 years or older; Patients who have given informed consent to participate in this study; Proficient in Chinese with no comprehension barriers; Capable of independently using internet-enabled mobile devices.
Who cannot join
None listed.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Construction and Preliminary Validation of a Community Health Education Program for Patients With Interstitial Lung Disease Based on Mobile Healthcare
This study analyzes the needs of patients regarding the content and form of home-based health education through interviews, and constructs a health education program tailored to these needs. A practical WeChat mini-program is developed to enable patients with interstitial lung disease to promptly access comprehensive health education information, consult about follow-up visits, and check test reports during their home care period, ultimately aiming to improve patients' quality of life and reduce medical consumption.
Read the detailed description
Interstitial Lung Disease (ILD) refers to a group of non-neoplastic and non-infectious diseases primarily affecting the alveolar walls, including lesions in the perialveolar tissues and adjacent supporting structures. It is characterized by progressive dyspnea, deteriorating lung function, and poor prognosis. In recent years, with the deterioration of air quality, the continuous advancement of diagnosis and treatment technologies, and physicians' deepened understanding of ILD, the diagnosis rate of ILD has been increasing year by year. As the detection rate rises, growing attention is paid to the survival and treatment of ILD patients.
ILD patients often experience labored and rapid breathing, which limits their ability to perform daily activities. Low levels of physical function and vitality, coupled with severe dyspnea and fatigue, lead to a poor quality of life for these patients. Currently, clinical treatments can only control disease progression to a certain extent. Enhancing ILD patients' knowledge of their condition, encouraging active participation of patients and their families in nursing care, and improving patients' ability to monitor and manage their own health can effectively reduce the risk of infections, ensure the clinical efficacy of implemented treatment plans, and further alleviate patients' clinical symptoms.
With societal progress and advances in medical technology, telemedicine has gradually been applied in clinical practice. Telemedicine interventions have proven beneficial for the home-based management and control of chronic diseases such as hypertension and diabetes. Therefore, integrating telemedicine with existing medical and nursing approaches for the home-based health guidance of ILD patients constitutes an innovative research with significant scientific value.
- Being tested
- The use and guidance of the mini-program
- Medical subject headings
- Noncommunicable Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The use and guidance of the mini-programBehavioural
Interventions were conducted through routine health education, telephone follow-ups, and questionnaire surveys during reconsultations. Health education covered disease knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up by telephone or home visit once a month, and questionnaire data were collected during their reconsultations. The use of a mini-program was added with corresponding guidance: patients were instructed to proficiently use the mini-program's functions for accessing health education information, interacting with medical staff, and noting key points for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to skillfully use the mini-program to push health education-related knowledge to patients at irregular intervals, and medical staff were trained on the effective collection of questionnaire data and data statistics.
| Study group | Role | What they receive |
|---|---|---|
| Control Group | Intervention Measures for the Control Group: Patients in the control group received interventions through routine health education, telephone follow-up, and questionnaire surveys during follow-up visits. Health education covered disease-related knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up once a month via telephone or home visit, and questionnaire data were collected during their follow-up consultations. | |
| Experimental Group | Intervention Measures for the Experimental Group: On the basis of routine health education, the experimental group additionally received guidance on the use of the mini-program. Patients were instructed to proficiently use the mini-program's functions, including accessing health education information, interacting with medical staff, and understanding the precautions for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to master the mini-program to irregularly push health education-related knowledge to patients, and medical staff were instructed on the effective collection of questionnaire data and data statistics. Receives: Behavioral: The use and guidance of the mini-program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Improve patients' quality of life and reduce medical consumption
Guide doctors and nurses to proficiently use the mini-program to push health education-related knowledge to patients at irregular intervals, and instruct medical staff on the effective collection of questionnaire data and data statistics.
Measured: One year after the start of recruitment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2025
- Study start30 Dec 2025 (estimated)
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Non-neoplastic and Non-infectious DiseasesStudies of the same condition, open and under way.
- More trials run by The Fourth Affiliated Hospital of Zhejiang University School of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 92 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07301398
- Sponsor's protocol ID
- KY-2025-126
- Status last verified
- Dec 2025
- First submitted
- 11 Dec 2025
- Last updated
- 24 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Construction and Preliminary Validation of a Community Health Education Program for Patients With Interstitial Lung Disease Based on Mobile Healthcare
- ClinicalTrials.gov ID
- NCT07301398
- Acronym / sponsor ID
- KY-2025-126
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 92 participants (estimated)
- Lead sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of MedicineUniversity, hospital or other
- Study start
- 30 Dec 2025 (estimated)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 24 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study analyzes the needs of patients regarding the content and form of home-based health education through interviews, and constructs a health education program tailored to these needs. A practical WeChat mini-program is developed to enable patients with interstitial lung disease to promptly access comprehensive health education information, consult about follow-up visits, and check test reports during their home care period, ultimately aiming to improve patients' quality of life and reduce medical consumption.
Detailed description
Interstitial Lung Disease (ILD) refers to a group of non-neoplastic and non-infectious diseases primarily affecting the alveolar walls, including lesions in the perialveolar tissues and adjacent supporting structures. It is characterized by progressive dyspnea, deteriorating lung function, and poor prognosis. In recent years, with the deterioration of air quality, the continuous advancement of diagnosis and treatment technologies, and physicians' deepened understanding of ILD, the diagnosis rate of ILD has been increasing year by year. As the detection rate rises, growing attention is paid to the survival and treatment of ILD patients.
ILD patients often experience labored and rapid breathing, which limits their ability to perform daily activities. Low levels of physical function and vitality, coupled with severe dyspnea and fatigue, lead to a poor quality of life for these patients. Currently, clinical treatments can only control disease progression to a certain extent. Enhancing ILD patients' knowledge of their condition, encouraging active participation of patients and their families in nursing care, and improving patients' ability to monitor and manage their own health can effectively reduce the risk of infections, ensure the clinical efficacy of implemented treatment plans, and further alleviate patients' clinical symptoms.
With societal progress and advances in medical technology, telemedicine has gradually been applied in clinical practice. Telemedicine interventions have proven beneficial for the home-based management and control of chronic diseases such as hypertension and diabetes. Therefore, integrating telemedicine with existing medical and nursing approaches for the home-based health guidance of ILD patients constitutes an innovative research with significant scientific value.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control Group | – | –Intervention Measures for the Control Group: Patients in the control group received interventions through routine health education, telephone follow-up, and questionnaire surveys during follow-up visits. Health education covered disease-related knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up once a month via telephone or home visit, and questionnaire data were collected during their follow-up consultations. |
| Experimental Group | – | Behavioral: The use and guidance of the mini-programIntervention Measures for the Experimental Group: On the basis of routine health education, the experimental group additionally received guidance on the use of the mini-program. Patients were instructed to proficiently use the mini-program's functions, including accessing health education information, interacting with medical staff, and understanding the precautions for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to master the mini-program to irregularly push health education-related knowledge to patients, and medical staff were instructed on the effective collection of questionnaire data and data statistics. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Complicated with other life-threatening diseases; Consciousness disturbance or mental illness; Currently participating in other clinical trials that may affect this study.
Key inclusion criteria (1 listed)
- Patients diagnosed with interstitial lung disease; Aged 18 years or older; Patients who have given informed consent to participate in this study; Proficient in Chinese with no comprehension barriers; Capable of independently using internet-enabled mobile devices.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The use and guidance of the mini-programInterventions were conducted through routine health education, telephone follow-ups, and questionnaire surveys during reconsultations. Health education covered disease knowledge, medication guidance, rehabilitation guidance, dietary guidance, and psychological guidance. After discharge, patients were followed up by telephone or home visit once a month, and questionnaire data were collected during their reconsultations. The use of a mini-program was added with corresponding guidance: patients were instructed to proficiently use the mini-program's functions for accessing health education information, interacting with medical staff, and noting key points for questionnaire completion, and were advised to fill out the questionnaire monthly. Doctors and nurses were guided to skillfully use the mini-program to push health education-related knowledge to patients at irregular intervals, and medical staff were trained on the effective collection of questionnaire data and data statistics. | Behavioural | Experimental Group |
Primary outcome
Improve patients' quality of life and reduce medical consumption
Time frame: One year after the start of recruitment
Guide doctors and nurses to proficiently use the mini-program to push health education-related knowledge to patients at irregular intervals, and instruct medical staff on the effective collection of questionnaire data and data statistics.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Non-neoplastic and Non-infectious Diseases
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Active, not recruitingObservational study
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active, not recruitingPhase 1
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma
Enrolling by invitationPhase 1
Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection
HPV 16 Infection, HPV-Related Carcinoma
RecruitingObservational study
Liver Disease and Other Systemic Diseases
Liver Diseases, Humans
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Non-neoplastic and Non-infectious Diseases, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact zhangying Zhang (+8613858102252, glfaizy@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Improve patients' quality of life and reduce medical consumption (time frame: One year after the start of recruitment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.